Email bulletin archive Archive November 2014 News from The Liver Meeting Interferon-free treatment: sofosbuvir/ledipasvir Decompensated cirrhosis HIV and hepatitis C co-infection Interferon-free treatment: other regimens for HCV genotype 1 A single interferon-free treatment for multiple genotypes? Interferon-free treatment for genotype 4 infection Survival AbbVie '3D' interferon-free combination receives scientific approval in European Union Hepatitis C treatment factsheets Is this your copy of the infohep news bulletin? October 2014 Cost and access issues Harvoni approved in US Petition for improved HCV diagnosis and treatment for people in Europe who use drugs Egypt infection control Hepatitis C treatment factsheets Is this your copy of the infohep news bulletin? September 2014 Daclatasvir (Daklinza) approved in the EU Universal access to hepatitis C treatment in the EU Access to hepatitis C treatment outside the EU and US US insurance restrictions and barriers to treatment Pricing of sofosbuvir / ledipasvir First European Conference on hepatitis C and harm reduction Hepatitis C treatment factsheets Is this your copy of the infohep news bulletin? July 2014 Daclatasvir recommended for European approval Hepatitis C treatment during opioid substitution therapy Hepatitis C treatment for people with HIV and hepatitis C co-infection Hepatitis C treatment factsheets Customise your hepatitis information Is this your copy of the infohep news bulletin? June 2014 Disease and healthcare utilisation burden without treatment Recent European decisions on reimbursement for sofosbuvir treatment of hepatitis C Merck buys Idenix to improve its hepatitis C portfolio BMS aims to test four-week treatment course for HCV Faldaprevir discontinued Achillion development plans Getting ready for World Hepatitis Day? New! Hepatitis C treatment factsheets New! Customise your hepatitis information Is this your copy of the infohep news bulletin? May 2014 Simeprevir marketing approval Hepatitis B screening recommendations Sofosbuvir for treatment of genotype 4 hepatitis C Sofosbuvir for treatment of post-transplant hepatitis C recurrence US health insurers question the price of sofosbuvir New! Hepatitis C treatment factsheets New! Customise your hepatitis information Is this your copy of the infohep news bulletin? April 2014 New European treatment guidelines for hepatitis C World Health Organization issues treatment guidelines for hepatitis C Access Hepatitis C treatment news from the International Liver Congress Prevention of hepatitis C infection Hepatitis B treatment Hepatitis delta treatment New! Hepatitis C treatment factsheets New! Customise your hepatitis information Is this your copy of the infohep news bulletin? March 2014 Shorter treatment is possible for hard-to-treat patients Simeprevir – new HCV protease inhibitor AbbVie '3D' combination highly potent treatment for genotype 1b infection HIV co-infection Other interferon-free combinations on the way European policy Cost of treatment Access to treatment Egypt negotiates 99% discount on sofosbuvir price Forthcoming events Is this your copy of the infohep news bulletin? February 2014 Access to hepatitis C treatment Treat or wait? AbbVie completes interferon-free trials programme Gilead seeks approval for ledipasvir/sofosbuvir combination tablet Hepatitis C stroke risk Hepatitis B screening guidelines in US Is this your copy of the infohep news bulletin? January 2014 New US hepatitis C treatment guidelines New European hepatitis C treatment guidelines Sofosbuvir approval in European Union Sofosbuvir/ledipasvir results Daclatasvir filing in European Union Other new drugs news Is your organisation listed in the infohep services database? 2022202120202019201820172016201520142013 Other pages in this section Latest news All the news Conference news Email bulletin archive